DOI QR코드

DOI QR Code

Identification of Derivatives of Cobalt-binding BLM-A2 by NMR

  • Lee, Seongeon (Department of Applied Chemistry, Hanyang University) ;
  • Shin, Donghyuk (Department of Applied Chemistry, Hanyang University) ;
  • Woo, Sunhee (Department of Applied Chemistry, Hanyang University) ;
  • Won, Hoshik (Department of Applied Chemistry, Hanyang University)
  • Received : 2012.11.07
  • Accepted : 2012.12.10
  • Published : 2012.12.20

Abstract

Three different derivatives were obtained in the synthesis of cobalt-binding BLM-A2 and characterized by NMR and Mass spectrometry. It was found that Component 1 is Co(II)($2H_2O$)(BLM-A2), component 2 is Co(III)($OOH^-$)(BLM-A2) and component 3 is Co(III)($H_2O$)($OH^-$)(BLM-A2), respectively. Component 2 and 3 were interestingly dominated when CoBLM-A2 complex was synthesized under basic condition. In this experiment, it was revealed newly that the brown form (component 1) was 6-coordinated structure composed with not 5 ligands but 4 ligands from BLM-A2 and with $2H_2O$ as the axial ligands. The component 3 exhibiting a novel ligand configuration is found, and the structure of component 3 was observed to be very similar to that of component 1 in the kind of their ligands but one of the axial ligand is $OH^-$ instead of $H_2O$. These ligand configurations are different from the green form (component 2) exhibiting 6-coordinate structure composed of 5 ligands from BLM-A2 and one ligand of $OOH^-$, being consistent with former studies.

Keywords

References

  1. H. Umezawa, K. Maeda, T. Takeuchi, Y. Okami, J. Antibiot. 19A, 200 (1966).
  2. H. Umezawa, Bleomycin: Current Status and New Developments, Academic Press, New York. 15 (1978).
  3. B. I. Sikic, Bleomycin Chemotherapy, Academic Press, Orlando, FL. (1985).
  4. J. Stubbe, J. W. Kozarich, Chem. Rev. 87, 1107 (1987). https://doi.org/10.1021/cr00081a011
  5. A. Natrajan, S. M. Hecht, Molecular Aspects of Anticancer Drug-DNA Interactions Vol. 2, MacMillan Press, London. 97 (1993).
  6. S. A. Kane, S. M. Hecht, Prog. Nucleic Acid Res. Mol. Biol. 49, 313 (1994). https://doi.org/10.1016/S0079-6603(08)60054-9
  7. S. M. Hecht, Bioconjugate Chem. 5, 513 (1994). https://doi.org/10.1021/bc00030a006
  8. S. M. Hecht, Cancer Chemotherapeutic Agents Foye, W., Ed. American Chemical Society, Washington, DC. 369 (1995).
  9. J. C. Dabrowiak, Adv. Inorg. Chem. 4, 69 (1982).
  10. D. H. Petering, R. W. Byrnes, W. E. Antholine, Chem. Biol. Interact. 73, 133 (1990). https://doi.org/10.1016/0009-2797(90)90001-4
  11. A. H. Thomas, P. Newland, N. R. Sharma, J. Chromatogr. 337, 219 (1984).
  12. R. P. Klett, J. P. Chovan, J. Chromatogr. 337, 182 (1985). https://doi.org/10.1016/0378-4347(85)80028-1
  13. W. Wu, D. E. Vanderwall, S. M. Lui, X. J. Tang, C. J. Turner, J. W. Kozarich, J. Stubbe, J., J. Am. Chem. Soc. 118, 1268 (1996). https://doi.org/10.1021/ja9524964
  14. S. M. Lui, D. E. Vanderwall, W. Wu, X. J. Tang, C. J. Turner, J. W. Kozarich, J. Stubbe, J. J. Am. Chem. Soc. 119, 9603 (1997). https://doi.org/10.1021/ja963889l
  15. M. A. J. Akkerman, C. A. G. Haasnoot, C. w. Hilbers, Eur. J. Biochem. 173, 211 (1988). https://doi.org/10.1111/j.1432-1033.1988.tb13987.x
  16. M. A. J. Akkerman, E. W. J. F. Neijman, S. S. Wijmenga, C. W. Hilbers, W. Bermel, J. Am. Chem. Soc. 112, 7462 (1990). https://doi.org/10.1021/ja00177a003
  17. P. Fulmer, C. Q. Zhao, W. B. Li, E. Derose, W. E. Antholine, D. H. Petering, Biochemistr 36, 4367 (1997). https://doi.org/10.1021/bi9625354
  18. J. Cacerescortes, H. Sugiyama, K. Ikudome, I. Saito, A. H. J. Wang, Eur J. Biochem. 244, 818 (1997). https://doi.org/10.1111/j.1432-1033.1997.00818.x
  19. Y. Iitaka, H. Nakamura, T. Nakatani, Y. Muraoka, A. Fujii, T. Takita, H. Umezawa, J. Antibiot. 31, 1070 (1978). https://doi.org/10.7164/antibiotics.31.1070
  20. D. Kim, M. Lee, C. Lee, H. Won, H., J. Kor. Mag. Reson. 10, 163 (2006).
  21. D. Kim. H. Won, J. Kor. Mag. Reson. 2, 50 (1998)